AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metdot 500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ablus Pharma

Salt Composition

Metformin (500mg)

Overview Metdot 500mg Tablet SR

Metformin 500mg Extended-Release tablets manage type 2 diabetes by regulating blood glucose, mitigating the risk of associated complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, take Metformin 500mg ER tablets with food, consistently at the same time daily. Discontinue use only under your physician's guidance. Maintaining a healthy lifestyle, including diet and exercise as prescribed, is crucial for diabetes management. Common side effects may include nausea, vomiting, diarrhea, abdominal pain, flatulence, weakness, indigestion, headache, and appetite changes. Hypoglycemia (low blood sugar) can occur, particularly when combined with other diabetes medications, alcohol, or missed meals; diligent blood glucose monitoring is essential. Consult your doctor before use if you have kidney, liver, or heart conditions, are pregnant, breastfeeding, or have other health concerns. Pre-treatment kidney function assessment will be conducted by your physician. Limit alcohol consumption to reduce the likelihood of adverse reactions.

Uses of Metdot 500mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metdot 500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metdot 500mg sustained-release tablet should be administered with a meal.

Common Side effects of Metdot 500mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metdot 500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metdot 500mg sustained-release tablet should be taken with a meal.

How Metdot 500mg Tablet SR works:

Metformin 500mg Extended-Release tablets are a biguanide-class drug used to manage diabetes. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metdot 500mg SR tablets is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metdot 500mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Extended-release Metdot 500mg tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Metdot 500mg Tablet SR requires careful administration; dosage modification may be necessary. Physician consultation is advised. In cases of severely compromised kidney function, Metdot 500mg Tablet SR is contraindicated.

LiverLiverUNSAFE

Extended-release Metdot 500mg tablets are contraindicated in individuals with hepatic impairment and should be omitted. Physician consultation is recommended.

What if you forget to take Metdot 500mg Tablet SR :

Should you forget a Metdot 500mg Tablet SR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metdot 500mg Tablet SR

LabelValue
Type of Compound Biguanide-based compound
Addictive None.
Type of Medication Diabetes medication

FAQs on Metdot 500mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's own insulin. This results in elevated blood glucose concentrations. Metdot 500mg Tablet SR employs a multifaceted approach to lower these elevated sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and improves the body's natural insulin response.
Metdot 500mg SR tablets have demonstrated weight reduction in overweight and obese patients. This effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, weight loss can occur in patients with insulin sensitivity or resistance issues. However, self-medicating with this drug for weight management is inadvisable; physician consultation is necessary.
Metdot 500mg Extended-Release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike many other oral hypoglycemics, Metdot 500mg Extended-Release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism of action, which avoids excessive pancreatic insulin release. Beyond glycemic control, this medication also aids in weight management.
Metdot 500mg sustained-release tablets generally don't induce drowsiness and are well-received. Infrequently, however, Metdot 500mg sustained-release tablets might lead to sleep disturbances or insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Seek medical attention if fatigue or sleepiness develops during Metdot 500mg sustained-release tablet use.
Administer Metdot 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume with breakfast. Twice-daily prescriptions should be divided, one with breakfast, the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Ingesting Metdot 500mg SR with food mitigates potential gastrointestinal issues such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. Consequently, blood glucose levels elevate. Metdot 500mg Tablet SR employs a multi-faceted approach to lower these elevated blood sugar levels. This medication reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metdot 500mg SR tablets have demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience weight loss. However, self-prescribing Metdot 500mg SR tablets for weight management is inadvisable; physician consultation is essential.
Metdot 500mg Extended-Release tablets are frequently an initial treatment for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, Metdot 500mg Extended-Release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism which avoids excessive insulin release from the pancreas. Beyond glycemic control, this medication also aids in weight management.
Metdot 500mg extended-release tablets generally don't induce drowsiness and are well-received. Infrequently, though, Metdot 500mg extended-release tablets can lead to sleep disturbances and insomnia. Somnolence might indicate a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metdot 500mg extended-release tablet use.
Administer Metdot 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest the tablet whole with water. For once-daily prescriptions, take the tablet in the morning with breakfast. For twice-daily regimens, distribute the dose between morning and evening meals. Three times daily, incorporate a dose with lunch in addition to morning and evening administrations. Consuming Metdot 500mg SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to the insulin they produce. This leads to elevated blood glucose concentrations. Metdot 500mg Tablet SR works through multiple mechanisms to lower these heightened blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream. Consequently, it improves the body's natural insulin response.
Metdot 500mg sustained-release tablets have demonstrated weight reduction benefits in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals with prediabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-initiation of Metdot for weight management is strongly discouraged; medical consultation is essential.
Metdot 500mg Tablet SR is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metdot 500mg Tablet SR, when used independently, infrequently leads to hypoglycemia due to its inhibition of excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
Metdot 500mg sustained-release tablets generally don't induce drowsiness and are well-received. Infrequently, however, Metdot 500mg sustained-release tablets may lead to sleep disturbances and insomnia. Drowsiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician immediately if fatigue or sleepiness develops during Metdot 500mg sustained-release tablet treatment.
Administer Metdot 500mg Tablet SR with food or following a meal. Avoid crushing or chewing the tablets; ingest them whole with water. For once-daily regimens, consume the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metdot 500mg Tablet SR with meals mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metdot 500mg Tablet SR
16
MRP 19
15% off